Validation of Prognostic Club Cell Secretory Protein (CC16) Cut-point in an Independent ALTA Cohort
CONCLUSION: In this validation study, we demonstrated that ARDS patients with high plasma CC16 concentration had a higher mortality rate than those with low CC16 levels, confirming previous findings that CC16 levels are associated with ARDS mortality.PMID:36814995 | PMC:PMC9940244 | DOI:10.1177/11772719231156308 (Source: Biomarker Insights)
Source: Biomarker Insights - February 23, 2023 Category: General Medicine Authors: Sultan Almuntashiri Aaron Chase Andrea Sikora Duo Zhang Source Type: research
Validation of Prognostic Club Cell Secretory Protein (CC16) Cut-point in an Independent ALTA Cohort
CONCLUSION: In this validation study, we demonstrated that ARDS patients with high plasma CC16 concentration had a higher mortality rate than those with low CC16 levels, confirming previous findings that CC16 levels are associated with ARDS mortality.PMID:36814995 | PMC:PMC9940244 | DOI:10.1177/11772719231156308 (Source: Biomarker Insights)
Source: Biomarker Insights - February 23, 2023 Category: General Medicine Authors: Sultan Almuntashiri Aaron Chase Andrea Sikora Duo Zhang Source Type: research
Validation of Prognostic Club Cell Secretory Protein (CC16) Cut-point in an Independent ALTA Cohort
CONCLUSION: In this validation study, we demonstrated that ARDS patients with high plasma CC16 concentration had a higher mortality rate than those with low CC16 levels, confirming previous findings that CC16 levels are associated with ARDS mortality.PMID:36814995 | PMC:PMC9940244 | DOI:10.1177/11772719231156308 (Source: Biomarker Insights)
Source: Biomarker Insights - February 23, 2023 Category: General Medicine Authors: Sultan Almuntashiri Aaron Chase Andrea Sikora Duo Zhang Source Type: research
Validation of Prognostic Club Cell Secretory Protein (CC16) Cut-point in an Independent ALTA Cohort
CONCLUSION: In this validation study, we demonstrated that ARDS patients with high plasma CC16 concentration had a higher mortality rate than those with low CC16 levels, confirming previous findings that CC16 levels are associated with ARDS mortality.PMID:36814995 | PMC:PMC9940244 | DOI:10.1177/11772719231156308 (Source: Biomarker Insights)
Source: Biomarker Insights - February 23, 2023 Category: General Medicine Authors: Sultan Almuntashiri Aaron Chase Andrea Sikora Duo Zhang Source Type: research
Validation of Prognostic Club Cell Secretory Protein (CC16) Cut-point in an Independent ALTA Cohort
CONCLUSION: In this validation study, we demonstrated that ARDS patients with high plasma CC16 concentration had a higher mortality rate than those with low CC16 levels, confirming previous findings that CC16 levels are associated with ARDS mortality.PMID:36814995 | PMC:PMC9940244 | DOI:10.1177/11772719231156308 (Source: Biomarker Insights)
Source: Biomarker Insights - February 23, 2023 Category: General Medicine Authors: Sultan Almuntashiri Aaron Chase Andrea Sikora Duo Zhang Source Type: research
Validation of Prognostic Club Cell Secretory Protein (CC16) Cut-point in an Independent ALTA Cohort
CONCLUSION: In this validation study, we demonstrated that ARDS patients with high plasma CC16 concentration had a higher mortality rate than those with low CC16 levels, confirming previous findings that CC16 levels are associated with ARDS mortality.PMID:36814995 | PMC:PMC9940244 | DOI:10.1177/11772719231156308 (Source: Biomarker Insights)
Source: Biomarker Insights - February 23, 2023 Category: General Medicine Authors: Sultan Almuntashiri Aaron Chase Andrea Sikora Duo Zhang Source Type: research
Validation of Prognostic Club Cell Secretory Protein (CC16) Cut-point in an Independent ALTA Cohort
CONCLUSION: In this validation study, we demonstrated that ARDS patients with high plasma CC16 concentration had a higher mortality rate than those with low CC16 levels, confirming previous findings that CC16 levels are associated with ARDS mortality.PMID:36814995 | PMC:PMC9940244 | DOI:10.1177/11772719231156308 (Source: Biomarker Insights)
Source: Biomarker Insights - February 23, 2023 Category: General Medicine Authors: Sultan Almuntashiri Aaron Chase Andrea Sikora Duo Zhang Source Type: research
Validation of Prognostic Club Cell Secretory Protein (CC16) Cut-point in an Independent ALTA Cohort
CONCLUSION: In this validation study, we demonstrated that ARDS patients with high plasma CC16 concentration had a higher mortality rate than those with low CC16 levels, confirming previous findings that CC16 levels are associated with ARDS mortality.PMID:36814995 | PMC:PMC9940244 | DOI:10.1177/11772719231156308 (Source: Biomarker Insights)
Source: Biomarker Insights - February 23, 2023 Category: General Medicine Authors: Sultan Almuntashiri Aaron Chase Andrea Sikora Duo Zhang Source Type: research
Validation of Prognostic Club Cell Secretory Protein (CC16) Cut-point in an Independent ALTA Cohort
CONCLUSION: In this validation study, we demonstrated that ARDS patients with high plasma CC16 concentration had a higher mortality rate than those with low CC16 levels, confirming previous findings that CC16 levels are associated with ARDS mortality.PMID:36814995 | PMC:PMC9940244 | DOI:10.1177/11772719231156308 (Source: Biomarker Insights)
Source: Biomarker Insights - February 23, 2023 Category: General Medicine Authors: Sultan Almuntashiri Aaron Chase Andrea Sikora Duo Zhang Source Type: research
Validation of Prognostic Club Cell Secretory Protein (CC16) Cut-point in an Independent ALTA Cohort
CONCLUSION: In this validation study, we demonstrated that ARDS patients with high plasma CC16 concentration had a higher mortality rate than those with low CC16 levels, confirming previous findings that CC16 levels are associated with ARDS mortality.PMID:36814995 | PMC:PMC9940244 | DOI:10.1177/11772719231156308 (Source: Biomarker Insights)
Source: Biomarker Insights - February 23, 2023 Category: General Medicine Authors: Sultan Almuntashiri Aaron Chase Andrea Sikora Duo Zhang Source Type: research
Validation of Prognostic Club Cell Secretory Protein (CC16) Cut-point in an Independent ALTA Cohort
CONCLUSION: In this validation study, we demonstrated that ARDS patients with high plasma CC16 concentration had a higher mortality rate than those with low CC16 levels, confirming previous findings that CC16 levels are associated with ARDS mortality.PMID:36814995 | PMC:PMC9940244 | DOI:10.1177/11772719231156308 (Source: Biomarker Insights)
Source: Biomarker Insights - February 23, 2023 Category: General Medicine Authors: Sultan Almuntashiri Aaron Chase Andrea Sikora Duo Zhang Source Type: research
Validation of Prognostic Club Cell Secretory Protein (CC16) Cut-point in an Independent ALTA Cohort
CONCLUSION: In this validation study, we demonstrated that ARDS patients with high plasma CC16 concentration had a higher mortality rate than those with low CC16 levels, confirming previous findings that CC16 levels are associated with ARDS mortality.PMID:36814995 | PMC:PMC9940244 | DOI:10.1177/11772719231156308 (Source: Biomarker Insights)
Source: Biomarker Insights - February 23, 2023 Category: General Medicine Authors: Sultan Almuntashiri Aaron Chase Andrea Sikora Duo Zhang Source Type: research
Validation of Prognostic Club Cell Secretory Protein (CC16) Cut-point in an Independent ALTA Cohort
CONCLUSION: In this validation study, we demonstrated that ARDS patients with high plasma CC16 concentration had a higher mortality rate than those with low CC16 levels, confirming previous findings that CC16 levels are associated with ARDS mortality.PMID:36814995 | PMC:PMC9940244 | DOI:10.1177/11772719231156308 (Source: Biomarker Insights)
Source: Biomarker Insights - February 23, 2023 Category: General Medicine Authors: Sultan Almuntashiri Aaron Chase Andrea Sikora Duo Zhang Source Type: research
Validation of Prognostic Club Cell Secretory Protein (CC16) Cut-point in an Independent ALTA Cohort
CONCLUSION: In this validation study, we demonstrated that ARDS patients with high plasma CC16 concentration had a higher mortality rate than those with low CC16 levels, confirming previous findings that CC16 levels are associated with ARDS mortality.PMID:36814995 | PMC:PMC9940244 | DOI:10.1177/11772719231156308 (Source: Biomarker Insights)
Source: Biomarker Insights - February 23, 2023 Category: General Medicine Authors: Sultan Almuntashiri Aaron Chase Andrea Sikora Duo Zhang Source Type: research
Validation of Prognostic Club Cell Secretory Protein (CC16) Cut-point in an Independent ALTA Cohort
CONCLUSION: In this validation study, we demonstrated that ARDS patients with high plasma CC16 concentration had a higher mortality rate than those with low CC16 levels, confirming previous findings that CC16 levels are associated with ARDS mortality.PMID:36814995 | PMC:PMC9940244 | DOI:10.1177/11772719231156308 (Source: Biomarker Insights)
Source: Biomarker Insights - February 23, 2023 Category: General Medicine Authors: Sultan Almuntashiri Aaron Chase Andrea Sikora Duo Zhang Source Type: research
